CGON position history
The shares of CG Oncology (CGON) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 8,000 shares, $208K, <0.01% of portfolio, New
- 2025 Q3: 16,000 shares, $644K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 8,000 shares, $332K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 674,000 shares, $46M, 0.26% of portfolio, Add +8325.0%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|